Director, Commercial Operations Gene Therapy
Catalent Pharma Solutions
Summary
Catalent is seeking a Director, Commercial Operations to join our gene therapy manufacturing facility. The Commercial Operations team serves as the vital link between our clients and site operations. Responsible for end-to-end commercial ownership across existing customer relationships and new business integration, this team drives pricing strategy, contract negotiations, revenue tracking, and account management to turn signed opportunities into life-saving commercial therapies.
Job description
Key Responsibilities
- Serve as the site commercial lead and key relationship manager for new and existing clients, maintaining high-touch communication and driving seamless technical transfers to routine commercial production.
- Partner with Business Development and Site Finance to establish robust commercial pricing, evaluate Cost of Goods Sold (COGS), enforce value pricing strategies, and capture current fiscal year revenue opportunities.
- Direct client contract lifecycles—including Commercial Supply Agreements (CSAs), Development & Licensing Agreements, and term sheets—ensuring complete capture of fees, price escalations, KPIs, and forecast commitments.
- Embed within the Site Leadership Team, working directly with the Site GM, Supply Chain, MSTAT, Operations, Quality, and Project Management to optimize site revenue, manage Accounts Receivable, and resolve client disputes.
- Oversee site S&OP revenue input, funnel forecasting, and lead site-wide Revenue Leakage mitigation through rigorous tracking, training, and governance.
- Elevate the client experience by hosting high-impact client site visits and continuous program updates.
Required Qualifications
- Minimum of 5+ years of direct experience within a Contract Development and Manufacturing Organization (CDMO) environment across technical project management, commercial operations, quality, or business development.
- Ability to work 100% onsite at our Harmans, MD facility 5 days a week.
- Bachelor’s degree in a relevant science, engineering, or business discipline.
- Comprehensive understanding of drug development processes, scale-up, GMP manufacturing, analytical research, quality systems, and regulatory expectations.
- Proven track record in direct contract negotiation, pricing architecture, COGS analysis, and financial acumen within a matrixed organization.
Preferred Qualifications
- Extensive direct commercial or operational experience specifically in Gene Therapy manufacturing.
- MBA or advanced technical/scientific degree.
- Advanced proficiency with ERP, MRP, and CRM platforms.
Requirements
- Minimum of 5+ years of direct experience within a Contract Development and Manufacturing Organization (CDMO) environment across technical project management, commercial operations, quality, or business development.
- Ability to work 100% onsite at our Harmans, MD facility 5 days a week.
- Bachelor’s degree in a relevant science, engineering, or business discipline.
- Comprehensive understanding of drug development processes, scale-up, GMP manufacturing, analytical research, quality systems, and regulatory expectations.
- Proven track record in direct contract negotiation, pricing architecture, COGS analysis, and financial acumen within a matrixed organization.
- Extensive direct commercial or operational experience specifically in Gene Therapy manufacturing.
- MBA or advanced technical/scientific degree.
- Advanced proficiency with ERP, MRP, and CRM platforms.
Benefits
- Medical, Dental & Vision
- Paid Time Off
- Holiday Schedule
- 401(k) Matching
- Incentive Opportunity
Company overview
Catalent Pharma Solutions, now known as Catalent, Inc., is a leading global contract development and manufacturing organization (CDMO) headquartered in Tampa, Florida. Founded in 2007 as a spin-off from Cardinal Health's pharmaceutical technologies segment, the company has grown into a major player in the pharmaceutical services industry. Catalent provides comprehensive drug development and manufacturing solutions including drug delivery technologies, formulation development, analytical testing, clinical and commercial manufacturing, clinical packaging, and supply chain services. The company operates over 50 facilities across four continents and has supported more than half of all FDA-approved products over the past decade. With approximately 16,900 employees, Catalent produces over 70 billion doses annually for more than 8,000 products, serving major pharmaceutical companies like Pfizer, Moderna, Novo Nordisk, and Bristol-Myers Squibb. In 2024, the company was acquired by Novo Holdings A/S for $16.5 billion, further strengthening its position in the global pharmaceutical manufacturing landscape.